Written by Klarity Editorial Team
Published: Jul 11, 2026

Last updated: July 11, 2026
If you have Cigna health insurance in Mississippi and are looking for weight loss treatment, one of the first questions you’ll have is whether your plan covers GLP-1 medications like Wegovy or Zepbound, and what you’ll need to do to access them. Cigna uses Express Scripts (ESI) as its pharmacy benefits manager, and understanding how ESI structures weight loss drug coverage can save you significant time and money before your first appointment.
This guide breaks down exactly how Cigna and Express Scripts handle weight loss medication coverage in Mississippi in 2026, including formulary tiers, prior authorization requirements, and what to expect if your plan includes prescription weight loss benefits.
Check If Your Plan May Cover Weight Loss Treatment →
Cigna commercial plans may cover prescription weight loss medications depending on your specific plan and employer benefit design. Coverage for weight loss drugs is not mandated by most commercial group plans, so whether medications like Wegovy, Zepbound, or Qsymia are available on your formulary depends on whether your employer opted into weight loss drug benefits when selecting plan features.
For plans that do include prescription weight loss coverage, Express Scripts manages the drug formulary. The ESI formulary for weight loss medications in 2026 is structured as follows:
An important distinction for patients comparing insurers: Cigna/ESI did not remove Zepbound from its formulary. CVS Caremark (the PBM for Aetna and many other plans) removed Zepbound effective July 1, 2025, and reinstated it on October 1, 2026. Throughout that period, Cigna/ESI members whose plans included weight loss drug coverage could still access Zepbound at Tier 3–4 with prior authorization. If Zepbound coverage continuity matters to you, this is a meaningful differentiator when comparing Mississippi insurance options.
| Medication | Drug Class | ESI Tier | PA Required? | DEA Schedule |
|---|---|---|---|---|
| Orlistat (Xenical, Alli) | Lipase Inhibitor | Tier 1–2 | No (typically) | Non-scheduled |
| Phentermine | Sympathomimetic Amine | Tier 1–2 | Sometimes | Schedule IV |
| Contrave (naltrexone/bupropion) | Combination | Tier 2–3 | Often required | Non-scheduled |
| Qsymia (phentermine/topiramate) | Combination | Tier 2–3 | Often required | Schedule IV |
| Saxenda (liraglutide) | GLP-1 Receptor Agonist | Tier 3–4 | Yes | Non-scheduled |
| Wegovy (semaglutide) | GLP-1 Receptor Agonist | Tier 3–4 | Yes | Non-scheduled |
| Zepbound (tirzepatide) | GIP/GLP-1 Dual Agonist | Tier 3–4 | Yes | Non-scheduled |
Tier placement and PA requirements vary by plan year and employer benefit design. Verify your specific plan’s formulary at mycigna.com or call 1-800-244-6224.
For GLP-1 medications and other Tier 3–4 weight loss drugs on Cigna/ESI plans, prior authorization is typically required. PA criteria for weight loss medications commonly include:
PA requests are submitted through Express Scripts. Your Klarity provider can prepare the clinical documentation and submit the PA request on your behalf.
Phentermine and Qsymia are both classified as Schedule IV controlled substances under the DEA. This is an important distinction for patients wondering about electronic prescribing restrictions.
Mississippi’s Electronic Prescribing for Controlled Substances (EPCS) law under Miss. Code Ann. § 456.44 applies only to Schedule II controlled substances. Because phentermine and Qsymia are Schedule IV (not Schedule II), the EPCS mandate does not apply to these medications. Klarity providers can prescribe phentermine and Qsymia via standard electronic transmission without EPCS hardware or protocols.
GLP-1 medications (Wegovy, Zepbound, Saxenda, Mounjaro) and Contrave/orlistat are entirely non-scheduled and have no controlled substance prescribing restrictions whatsoever.
Mississippi’s mental health parity law, Miss. Code Ann. § 83-9-353 et seq., requires that fully-insured commercial health plans offer mental health and substance use disorder benefits no more restrictively than medical/surgical benefits. This parity mandate applies to mental health conditions — it does not directly mandate coverage for weight loss medications or obesity treatment as a separate benefit category.
Whether your Cigna plan covers weight loss medications is determined by your employer’s benefit design, not Mississippi state law. Self-funded employer plans governed by ERISA are exempt from Mississippi state insurance mandates entirely — if your employer self-funds its health plan, neither the parity law nor any state coverage mandate applies.
To determine whether your specific Cigna plan includes weight loss drug benefits:
Cigna commercial plans generally cover telehealth visits, including appointments for weight loss evaluation and management, when provided by an in-network licensed provider. A telehealth visit with a Klarity provider typically counts as a standard medical visit for billing purposes, subject to your applicable copay or coinsurance.
Klarity Health connects Mississippi patients with licensed medical providers who can evaluate weight loss treatment options, determine clinical eligibility, initiate prior authorization for GLP-1 medications, and provide ongoing monitoring — all via telehealth without requiring an in-person clinic visit.
See If You May Qualify for Weight Loss Treatment →
If your employer plan does not include weight loss drug benefits, or if your prior authorization is denied, several options remain available:
Cigna/ESI did not remove Zepbound from its formulary, unlike CVS Caremark. If your Cigna plan includes weight loss drug benefits, Zepbound is typically available at Tier 3–4 with prior authorization. Coverage depends on your specific plan — verify at mycigna.com or by calling 1-800-244-6224.
Wegovy (semaglutide) may be covered under Cigna commercial plans that include prescription weight loss benefits. It typically sits at Tier 3–4 on the ESI formulary and requires prior authorization documenting BMI ≥ 30 (or ≥ 27 with comorbidity) and prior diet/lifestyle intervention. Coverage varies by employer plan.
Phentermine is generally available at lower tiers (Tier 1–2) on ESI formularies and may be accessible with lower cost share. As a Schedule IV substance (not Schedule II), it is not subject to Mississippi’s EPCS electronic prescribing mandate. Coverage depends on your plan’s benefit design.
Your prescribing provider submits a PA request directly to Express Scripts. Your Klarity provider handles this process on your behalf. PA requests typically require BMI documentation, comorbidity history, and prior treatment records. You can also call ESI at 1-800-835-3784 to check PA status.
Yes. Klarity providers are experienced in submitting prior authorization requests for weight loss medications including GLP-1 agents. Your provider will prepare the clinical documentation and submit the request to Express Scripts. You’ll be notified once a decision is made.
Verify Your Benefits and Start Treatment →
Important disclaimer: Coverage information on this page reflects general ESI formulary practices and publicly available Cigna plan documents as of July 2026. Actual coverage, prior authorization criteria, and cost share vary significantly by plan and employer benefit design. This page does not constitute insurance or medical advice. Verify your specific benefits directly with Cigna at 1-800-244-6224 or mycigna.com before scheduling an appointment. For independent review rights, contact the Mississippi Department of Insurance at 1-800-562-2957.
Find the right provider for your needs — select your state to find expert care near you.